HELIUS MEDICAL TECHNOLOGIES news, videos and press releases - Page 2
For more news please use our advanced search feature.
HELIUS MEDICAL TECHNOLOGIES - More news...
HELIUS MEDICAL TECHNOLOGIES - More news...
- Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results
- Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023
- Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685
- Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary
- Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device
- Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
- Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke
- Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
- Helius Medical Technologies to Present at the 35th Annual ROTH Conference
- Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
- Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
- Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023
- Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program
- Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis
- Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk
- Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
- Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results
- Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program
- Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program
- Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait
- Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022
- Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait
- Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference
- Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
- Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September
- Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results
- Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022
- Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering
- Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™
- Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting